Key | % Net Assets |
---|---|
Novartis AG | 3.9% |
Roche Holding AG Part. Cert. | 3.4% |
Banco Santander S.A. | 3.2% |
E.ON AG | 3.2% |
Other | 86.3% |
Name | % Net Assets |
---|---|
Novartis AG | 3.9% |
Roche Holding AG Part. Cert. | 3.4% |
Banco Santander S.A. | 3.2% |
E.ON AG | 3.2% |
France Telecom | 3.2% |
Bayer AG | 2.9% |
Telefonica S.A | 2.7% |
ING Groep N.V. | 2.6% |
Societe Generale | 2.5% |
Daimler AG | 2.5% |
No asset data available.
Date | 13-Sep-2018 |
---|---|
NAV | 246.37p |
Currency | GBP |
Change | 0.000p |
% | n/a |
YTD change | 246.37p |
YTD % | n/a |
Fund Inception | 02/06/1986 |
---|---|
Fund Manager | John Botham |
TER | 1.64 (15-Apr-2012) |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.08 |
You are here: research